Terms: = Germ cell tumor AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Staging
75 results:
1. Dabrafenib plus trametinib in unselected advanced braf V600-mut melanoma: a non-interventional, multicenter, prospective trial.
Richtig E; Nguyen VA; Koelblinger P; Wolf I; Kehrer H; Saxinger W; Ressler JM; Weinlich G; Meyersburg D; Hafner C; Jecel-Grill E; Kofler J; Lange-Asschenfeldt B; Weihsengruber F; Rappersberger K; Svastics N; Gasser K; Seeber A; Kratochvill F; Nagler S; Mraz B; Hoeller C
Melanoma Res; 2024 Apr; 34(2):142-151. PubMed ID: 38092013
[TBL] [Abstract] [Full Text] [Related]
2. Penile melanoma: a pathological report of two cases.
Pósfai B; Szentkereszty M; Sánta F; Bajory Z; Simon A; Kozéki Z; Csányi I; Akgul M; Kuthi L
Diagn Pathol; 2023 Oct; 18(1):117. PubMed ID: 37898793
[TBL] [Abstract] [Full Text] [Related]
3. Clinical practice consensus for the diagnosis and management of melanoma in Taiwan.
Wu CE; Liao YH; Wu CL; Yen RF; Lin CC; Yang MH; Yen CC; Su WC; Yen CJ; Chang YF; Wu MF; Yang Y; Lin CY; Yang WC; Wang HC; Li CY; Ho YY; Chang YY; Wu CS; Hsu HC; Chen KH; Huang Y; Chen CJ; Chuang PJ; Lai YC; Huang YY; Tseng NC; Huang YT; Chu CY; Wen-Cheng Chang J
J Formos Med Assoc; 2024 Jan; 123(1):7-15. PubMed ID: 37690868
[TBL] [Abstract] [Full Text] [Related]
4. A diagrammatic summary of updated NICE melanoma guidance: A simple way to mitigate human factors in MDTs and clinics.
Chin YR; Dickson J
J Plast Reconstr Aesthet Surg; 2023 Jun; 81():85-87. PubMed ID: 37121047
[TBL] [Abstract] [Full Text] [Related]
5. [Clinicopathological features and prognosis of anorectal melanoma: A report of 68 cases].
Lai YM; Li ZW; Li H; Wu Y; Shi YF; Zhou LX; Lou YT; Cui CL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):262-269. PubMed ID: 37042136
[TBL] [Abstract] [Full Text] [Related]
6. Clinical predictors of survival in real world practice in stage IV melanoma.
Hu HP; Archer C; Yip D; Peters G
Cancer Rep (Hoboken); 2023 Feb; 6(2):e1691. PubMed ID: 36161287
[TBL] [Abstract] [Full Text] [Related]
7. Metastatic malignant melanoma of the breast: report of a case and review of the literature.
Mastoraki A; Gkiala A; Theodoroleas G; Mouchtouri E; Strimpakos A; Papagiannopoulou D; Schizas D
Folia Med (Plovdiv); 2022 Apr; 64(2):354-358. PubMed ID: 35851793
[TBL] [Abstract] [Full Text] [Related]
8. Gliomas molecular markers: importance in treatment, prognosis and applicability in brazilian health system.
Soldatelli JS; Oliveira IM; Kneubil MC; Henriques JAP
An Acad Bras Cienc; 2022; 94(3):e20211075. PubMed ID: 35766600
[TBL] [Abstract] [Full Text] [Related]
9. Sinonasal Mucosal Melanoma: Role of tumor Proliferative Indices and Pathological Factors in Survival.
Guo R; Jenkins SM; Johnson BJ; Reed K; Kroneman T; Choby G
Laryngoscope; 2022 Dec; 132(12):2350-2358. PubMed ID: 35661370
[TBL] [Abstract] [Full Text] [Related]
10. Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy Prediction.
Tímár J; Ladányi A
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628196
[TBL] [Abstract] [Full Text] [Related]
11. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022.
Garbe C; Amaral T; Peris K; Hauschild A; Arenberger P; Basset-Seguin N; Bastholt L; Bataille V; Del Marmol V; Dréno B; Fargnoli MC; Forsea AM; Grob JJ; Hoeller C; Kaufmann R; Kelleners-Smeets N; Lallas A; Lebbé C; Lytvynenko B; Malvehy J; Moreno-Ramirez D; Nathan P; Pellacani G; Saiag P; Stratigos AJ; Van Akkooi ACJ; Vieira R; Zalaudek I; Lorigan P;
Eur J Cancer; 2022 Jul; 170():256-284. PubMed ID: 35623961
[TBL] [Abstract] [Full Text] [Related]
12. The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021.
Ascierto PA; Warner AB; Blank C; Caracò C; Demaria S; Gershenwald JE; Khushalani NI; Long GV; Luke JJ; Mehnert JM; Robert C; Rutkowski P; Tawbi HA; Osman I; Puzanov I
J Transl Med; 2022 May; 20(1):200. PubMed ID: 35538491
[TBL] [Abstract] [Full Text] [Related]
13. TMB and braf mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapy.
Eckardt J; Schroeder C; Martus P; Armeanu-Ebinger S; Kelemen O; Gschwind A; Bonzheim I; Eigentler T; Amaral T; Ossowski S; Rieß O; Flatz L; Garbe C; Forschner A
J Cancer Res Clin Oncol; 2023 Feb; 149(2):833-840. PubMed ID: 35192052
[TBL] [Abstract] [Full Text] [Related]
14. Multimodality Imaging and Genetics of Primary Mucosal Melanomas and Response to Treatment.
Saleh M; Javadi S; Elsherif S; Patnana M; Sagebiel TL; Torres-Cabala C; Mattei J; Bhosale P; Faria SC
Radiographics; 2021; 41(7):1954-1972. PubMed ID: 34678102
[TBL] [Abstract] [Full Text] [Related]
15. Melanoma brain metastases that progress on braf-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES).
Lau PKH; Feran B; Smith L; Lasocki A; Molania R; Smith K; Weppler A; Angel C; Kee D; Bhave P; Lee B; Young RJ; Iravani A; Yeang HA; Vergara IA; Kok D; Drummond K; Neeson PJ; Sheppard KE; Papenfuss T; Solomon BJ; Sandhu S; McArthur GA
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34625515
[TBL] [Abstract] [Full Text] [Related]
16. Multidisciplinary Care of braf-Mutant Stage III Melanoma: A Physicians Perspective Review.
Cornelius LA; Fields RC; Tarhini A
Oncologist; 2021 Sep; 26(9):e1644-e1651. PubMed ID: 34080754
[TBL] [Abstract] [Full Text] [Related]
17. Oncogene targeted therapy for metastatic primary scrotal melanoma.
Stocks B; Fuentes H; McDowell Z; Brooks M; Jones JA
Can J Urol; 2021 Apr; 28(2):10643-10647. PubMed ID: 33872566
[TBL] [Abstract] [Full Text] [Related]
18. Neoadjuvant Cytoreductive Treatment With braf/MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single-arm, Open-label Phase II Trial.
Blankenstein SA; Rohaan MW; Klop WMC; van der Hiel B; van de Wiel BA; Lahaye MJ; Adriaansz S; Sikorska K; van Tinteren H; Sari A; Grijpink-Ongering LG; van Houdt WJ; Wouters MWJM; Blank CU; Wilgenhof S; van Thienen JV; van Akkooi ACJ; Haanen JBAG
Ann Surg; 2021 Aug; 274(2):383-389. PubMed ID: 33843797
[TBL] [Abstract] [Full Text] [Related]
19. The "Great Debate" at Melanoma Bridge 2020: December, 5th, 2020.
Ascierto PA; Atkins MB; Eggermont AM; Gershenwald JE; Grob JJ; Hamid O; Sondak VK; Sosman JA; Tawbi HA; Weber JS; Caracò C; Osman I; Puzanov I
J Transl Med; 2021 Apr; 19(1):142. PubMed ID: 33827575
[TBL] [Abstract] [Full Text] [Related]
20. Novel adjuvant options for cutaneous melanoma.
Dimitriou F; Long GV; Menzies AM
Ann Oncol; 2021 Jul; 32(7):854-865. PubMed ID: 33771664
[TBL] [Abstract] [Full Text] [Related]
[Next]
